(Q36385176)

13 August 2017

1 reference

title

Ex vivo programmed cell death and the prediction of response to chemotherapy (English)

1 reference

13 August 2017

1 reference

1 reference

Robert A Nagourney

1

1 reference

PubMed ID

16455021

13 August 2017

language of work or name

1 reference

1 March 2006

1 reference

Current Treatment Options in Oncology

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

103-110

1 reference

13 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-006-0045-2

13 August 2017

0 references

cites work

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-006-0045-2

2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-006-0045-2

Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-006-0045-2

Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.

21 January 2018

1 reference

12 December 2020

Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer

1 reference

12 December 2020

Further observations on the effects of cancer chemotherapeutic agents on the in vitro dehydrogenase activity of cancer tissue.

1 reference

12 December 2020

The clinical relevance of chemosensitivity testing in ovarian cancer.

1 reference

12 December 2020

Predictive value of the fluorescent cytoprint assay (FCA): a retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapy

1 reference

12 December 2020

Dysregulation of apoptosis in cancer

1 reference

12 December 2020

Clinical applications of the histoculture drug response assay.

1 reference

12 December 2020

Limitations of the Fast Green Assay for Chemosensitivity Testing in Human Lung Cancer

1 reference

12 December 2020

Current status and future directions of chemosensitivity testing.

1 reference

12 December 2020

A novel dye exclusion method for testing in vitro chemosensitivity of human tumors

1 reference

12 December 2020

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer

1 reference

12 December 2020

In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Chemosensitivity testing in ovarian cancer.

1 reference

12 December 2020

A rapid drug sensitivity assay for neoplasmatic cells.

1 reference

12 December 2020

Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity

1 reference

12 December 2020

Reduction of MTT by flavonoids in the absence of cells

1 reference

12 December 2020

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

1 reference

12 December 2020

A new method for in vitro chemosensitivity assay: inhibition of metabolic CO2 production

1 reference

12 December 2020

Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results

1 reference

12 December 2020

An alternative, nonapoptotic form of programmed cell death

1 reference

12 December 2020

Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples

1 reference

12 December 2020

Genetic control of programmed cell death in the nematode C. elegans.

1 reference

12 December 2020

Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics

1 reference

12 December 2020

[Comparative study of histopathological effects of preoperative chemotherapy using UFT and in vitro MTT assay of colonoscopy specimens from patients with colorectal cancer].

1 reference

12 December 2020

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

1 reference

12 December 2020

C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2.

1 reference

12 December 2020

Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients

1 reference

12 December 2020

Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients

1 reference

12 December 2020

The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay.

1 reference

12 December 2020

Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro.

1 reference

12 December 2020

Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide

1 reference

12 December 2020

10.1007/S11864-006-0045-2

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16455021